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Background: Centralization of pancreatic surgery has proceeded in the last few years in many countries.
However, information on the effect of hospital volume speciﬁcally on distal pancreatic resections (DP) is
lacking.
Aim: To investigate the effect of hospital volume on postoperative complications in DP patients in
Finland.
Methods: All DP performed in Finland during the period 2012e2014 were analyzed, information having
been retrieved from the appropriate national registers. Hospital volumes, postoperative pancreatic
ﬁstulae (POPF) and overall complications were graded. High volume centre (HVC) was deﬁned as per-
forming> 10 DPs, median volume centre (MVC) 4e9 DPs and low volume centre (LVC) fewer than 4 DP
annually.
Results: A total of 194 DPs were performed at 18 different hospitals. Of these 42% (81) were performed in
HVCs (2 hospitals), 43% (84) in MVCs (6 hospitals) and the remaining 15% (29) in LVCs (10 hospitals).
Patient demographics did not differ between the hospital volume groups. The overall rate of clinically
relevant POPF, Clavien-Dindo grade 3e5 complications, and 90-day mortality showed no signiﬁcant
differences between the different hospital volumes. Grade C POPF was found more often in LVCs, being
1.2% in HVCs, 0% in MCVs and 6.9% in LVCs, p¼ 0.030. More reoperations were performed in LVCs (10.3%)
than in HVCs (1.2%) or MVCs (1.2%); p¼ 0.025.
Conclusions: Even though the rate of postoperative complications after DP is not affected by hospital
volume, reoperations were performed ten times more often in the low-volume centres. Optimal man-
agement of postoperative complications may favour centralization not only of PD, but also of DP.
© 2018 IAP and EPC. Published by Elsevier B.V. All rights reserved.Introduction
Centralization of treatment of pancreatic surgery reduces
postoperative mortality and morbidity and also improves long-
term survival after pancreatoduodenectomy (PD) [1e4].
Compared to PD, postoperative pancreatic ﬁstulas (POPF) are even
more common e though less life-threatening - after distal
pancreatectomy (DP) and overall morbidity also remains high
[5e7]. The effect of hospital volume on complications after DP hasnd Alimentary Tract Surgery,
mpere, Finland.
Laukkarinen).
r B.V. All rights reserved.not been widely studied [8]. The aim of this study was to analyze
whether hospital volume affects the rate of POPF and overall
morbidity after DP according to a nationwide database.Methods
All patients undergoing DP in the period 2012e2014 were
identiﬁed from the Finnish Operation and Treatment Register
(HILMO) using Nordic Classiﬁcation of Surgical Procedures codes
(ICD10 codes JLC10 and JLC11). All patient records were collected
and examined manually. Emergency operations and patients with
no data available were excluded.
Postoperative complications, POPF, mortality, reoperations and
Table 2
Final histopathological diagnoses: all patients.
Adenocarcinoma 40 (21%)
Neuroendocrine carcinoma 7(3,6%)
Intraductal papillary mucinous carcinoma 2(1%)
Gastrointestinal stromal carcinoma 1 (0,5%)
Kidney metastasis 6 (3%)
Colon carcinoma 1 (0,5%)
Neuroendocrine tumour 43 (22,%)
Mucinous cystic nesplasm 23(11,9%)
Intraductal papillary mucinous neoplasm 17 (8,8%)
Serous cystic neoplasm 20 (10%)
Solid pseudopapillary neoplasm 3 (1,5%)
Chronic pancreatitis 7 (3,6%)
Pseudocyst 7 (3,6%)
Gastrointestinal stromal tumour 1 (0,5%)
Cyst 5 (2,6%)
Fibrosis 1 (0,5%)
Spleen accessorius 7(3,6%)
Hemangioma 1(0,5%)
Nesidioblastooma 1(0,5%)
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also gathered. Complications were graded according to the Clavien-
Dindo classiﬁcation and grades 3e5 were considered major com-
plications [9]. Postoperative pancreatic ﬁstulas were graded ac-
cording to the new ISGPF classiﬁcation [10,11]. In grade B ﬁstula the
drain is left in place for over 3 weeks or repositioned through
percutaneous or endoscopic procedures. Grade C ﬁstula requires
either reoperation or leads to organ failure or death of the patient.
The ﬁnal histopathological diagnoses were also gathered.
The hospital DP volumes were calculated and the hospitals were
categorized according to operation volume. For this study, high-
volume centres (HVC) were deﬁned as those performing 10 or
more distal pancreatectomies per year Median-volume centres
(MVC) accomplished 4e9 DPs and low-volume centres (LVC) less
than 4 DPs per year.
Ethical approval for the study was granted by the Regional
Ethics Committee of Pirkanmaa, Finland (ETL code R12241).
Statistical analysis
Fisher's exact test and 2 test were used as appropriate to
calculate statistical differences. Statistical analysis was performed
with IBS SPSS statistics software. P 0.05 was considered statisti-
cally signiﬁcant.
Results
One hundred and ninety-four DPs were performed in Finland
between 2012 and 2014 in 18 different hospitals. There were two
HVCs, 6MVCs, and 10 LVCs. Of DPs 85% (165) were performed in
HVCs and MVCs (41% in HCVs and 44% in MVCs) and 15% (29) in
LVCs. In total 81 DP/3 yr were performed in HVCs, 84 in MVCs and
29 in LVCs.
Patient demographics or perioperative data did not differ be-
tween the centres (Table 1). Combined splenectomy (median 60%,
range 51e69%) and resection of other organs (16%, range 11e20%)
were performed without differences between the centres. Blood
loss (median 700ml, range 10e16000ml) and operative time
(median 187min, range 114e317min) were also similar regardless
of hospital volume. For pancreatic stump closure stapler was used
in 69% of patients, and the methods did not differ between the
groups. There were more laparoscopic procedures in HVCs and
MVCs than in LVCs (28%, 27% and 3% respectively, p¼ 0.008).
The proportion of malignant diseases was similar between the
centres. The ﬁnal histopathological diagnoses are shown in Table 2.
The overall rate for POPF (B/C) rate was 17.2% in all patients.
POPF occurred in 21% in HVCs, 10.7% in MVCs and 17.2% in LVCs.Table 1
Pre- and perioperative characteristics across the groups.
High-Volume centre n
(DP)¼ 81
Medium-volume ce
n(DP)¼ 84
Age, median, years (range) 62 (0.3e80) 65 (21e80)
Sex ratio (F/M) 45/36 60/24
BMI 26,1 (16e40) 23,6 (19e40)
Diabetes 20 (24,7%) 10 (14,1%)
Laparoscopic procedure 23 (28,4%) 23 (27,4%)
Combined resection of other
organs
9 (11,1%) 17 (20,2%)
Hand -sewn closure of the
pancreatic
25 (30,9%) 20 (23,8%)
Stapler closure of pancreatic stump 54 (66,7%) 64 (76,2%)
Splenectomy 42 (51,9%) 58 (69,0%)
Blood loss (ml) 850 (150e5300) 590 (0e16000)
Oper. time (min) 167 (115e317) 200 (114e377)
Number of hospitals 2 6Grade C POPF was found more often in LVCs, the rate being 1.2% in
HVCs, 0% in MCVs and 6.9% in LVCs, p¼ 0.030. The rate of intra-
abdominal collections was similar; they occurred respectively in
28%, 25%, and 20.7% in HVCs, MVCs and LVCs. Interventional drain
or pancreatic stent was used similarly in the centres to drain a
collection in the postoperative treatment of POPF. Delayed gastric
emptying (DGE) was found to be more common in LVCs (20.7%)
than in HVCs/MVCs (3.7%/10.7%; p¼ 0.018). However, no difference
was found in other complications such as postoperative pancrea-
titis, lymphatic leak, post-pancreatic hemorrhage (PPH), wound
infection, pneumonia or pulmonary embolism (Table 3).
Clavien-Dindo 3e5 complications occurred in 16.0% of HVC
patients, in MVCs in 18.1% of patients, and in LVCs in 20.7% of pa-
tients. In LVCs the rate for major complications tended to be higher,
but this was not statistically signiﬁcant (p¼ 0.81). Ninety-day
mortality was 0% in HVCs and in the LVC group and 2.4% in MVCs.
Signiﬁcantly more reoperations were performed in LVCs, on
10.3% of patients (3/29), than in HVCs and MVCs: 1.2% (1/82) and
1.2% (1/87) respectively, p¼ 0.025. Due to the small number of
reoperations, multivariate analysis was not possible. Out of the
three re-operated patients in the LVCs, the ﬁrst patient had POPF,
PPH and pneumonia and was treated in the ICU. He underwent
reoperation twice; on day 19 due to PPH and intra-abdominal
collection (splenectomy and drain repositioned) and on day 49
due to 15 cmwide peripancreatic collectionwith amylase-rich ﬂuid
(drain repositioned). The second patient underwent reoperation onntre Low-volume centre n
(DP)¼ 29
Overall volume n
(DP)¼ 194
67 (41e85) 64 (0,3e85)
17/12 122/72
28,4 (23e36) 26,1 (16e40)
8 (29,6%) 21,2% (38)
1(3,4%) 47 (24,2%) p¼ 0.008
4 (13,8%) 30 (15,5%)
11 (37,9%) 56 (28,9%)
16 (55,2%) 134 (69,1%)
16 (55,2%) 116 (59,8%)
500 (300e2500) 700 (0e16000)
180 (120e258) 187 (114e377)
10 18
Table 3
Postoperative complications in the groups.
% (n) High-volume centre n¼ 81 Medium-volume centre n¼ 84 Low-volume centre n¼ 29
Pancreatic Fistula
Grade B 19,8% (16) 10,7% (9) 10,3% (3)
Grade C 1,2% (1) 0,0% (0) 6,9% (2) P¼ 0,030
Grade B/C 21,0% (17) 10.7% (9) 17,2% (5)
PPH 4,9% (4) 4,8% (4) 6,9% (2)
DGE 3,7% (3) 10,7% (9) 20,7% (6) P¼ 0,018
Intra-abdominal collection 28,4% (23) 25,0% (21) 20,7% (6)
Interventional drain 13,6% (11) 11,9% (10) 10,3% (3)
Pancreatic stent 2,5% (2) 2,4% (2) 6,9% (2)
CT veriﬁed pancreatitis 3,7% (3) 2,4% (2) 0,0% (0)
Lympha leak 1,2% (1) 1,2%(1) 0,0% (0)
Wound-infection 9,9% (8) 3,6% (3) 10,3% (3)
Pneumonia 12,3% (10) 6,0% (5) 10,3% (3)
Pulmonary embolism 3,7% (3) 0,0% (0) 5,0% (1)
Clavien-Dindo III-V 16,0% (13) 18,1% (15) 20,7% (6)
Reoperation 1,2% (1) 1,2% (1) 10,3% (3) p¼ 0,025
Total hospital stay, median (range) 7 (3e25) 8 (3e30) 8 (5e40)
Readmission 16,3% (13) 13,1% (11) 24,1% (7)
90-day mortality 0,0% (0) 2,4% (2) 0,0% (0)
A. Antila et al. / Pancreatology 19 (2019) 26e3028day 8 due to infection and inadequate blood ﬂow to the spleen seen
in ultrasound (splenectomy, drain repositioned; produced amylase-
rich ﬂuid). The third patient underwent reoperation on day 10 due
to DGE (nasogastric tube repositioned, inﬂammation detected
around pancreas with jejunal loops attached). The indications for
reoperations in the HVC group were bowel necrosis caused by
atherosclerosis and prolonged infection due to POPF, and in the
MVC group ureter injury sustained in the primary operation.
Clavien-Dindo complication, reoperation and readdmission rates
are seen in Fig. 1.
Therewere no differences in total hospital stay, readmission rate
or 90-day mortality. These parameters are shown in Table 3. There
were two deaths within 90 days postoperatively, both in the MVC
group. The ﬁrst patient died on day 3. This patient had a BMI of 40,
and had breathing problems before his death, probably because of a
pulmonary embolism. The second patient died on day 12 due to
postoperative bleeding. Hemoglobin level was 23 g/l before her
death. She also had cholangitis and a choledochal stone had been
removed in endoscopic retrograde cholangiography (ERC) 2 days
earlier.
In univariate analysis, no single factor signiﬁcantly affecting the
formation of clinically relevant POPF was found. In all open pro-
cedures the clinically relevant ﬁstula rate was 17.2% and in the
laparoscopic procedures 12.8% (ns). Combined resection of otherFig. 1. Reoperation, Clavien-Dindo 3e5 grades and readdmission rates seen in different
centres. HVC¼ high volume centre, MVC¼median volume centre, LVC¼ low volume
centre).organs raised the ﬁstula rate up to 23.3% but without a signiﬁcant
difference between different centre volumes. In stapler closure and
in hand sewn closure groups the respective ﬁstula rates were 17%
and 17.0% (ns). Malignancy did not protect against ﬁstula formation,
the POPF rate being 14,2% in all malignant cases.Discussion
Ample evidence supports the centralization of PDs [12e16], but
it is not known whether it would be beneﬁcial also to centralize
DPs. Our aim was to study the effect of hospital volume on the
outcome of all DP operations performed nationwide in Finland
during the period 2012e2014. We found that the frequencies of
clinically relevant POPF and Clavien-Dindo 3e5 complications were
not related to hospital volume. However, the management of
complications differed signiﬁcantly, as more reoperations were
performed in the LVCs.
The reoperation rate in LVC was 10.3% and included three pa-
tients. One might speculate that these were all unnecessary. The
ﬁrst patient with PPH, POPF and intra-abdominal collection, who
twice underwent relaparotomy, could have been managed by
interventional radiological procedures. The second patient who had
an infection and inadequate blood ﬂow to the spleen on ultrasound
could have beenmanagedwithout laparotomy if a CT scan had been
performed. The third patient who underwent a laparotomy for DGE
could have been managed by watchful waiting, medical treatment,
and repeated imaging. Most of the postoperative complications,
which in the past may have needed surgery, can today be treated
with conservative or minimally invasive approaches. In the low-
volume centres the options for modern treatment may be limited.
A laparoscopic approach was taken, most often in HVCs and
MVCs. Overall, laparoscopy seems to be underutilized in DPs in
Finland, as the overall rate is so low (24%). Laparoscopic DP is
associated with signiﬁcantly less overall morbidity than open
technique. Blood loss is smaller and the length of hospital stay is
shorter [17]. However, no signiﬁcant difference in clinically relevant
POPF was found. In the LVCs laparoscopic approach was rare which
might be explained by the low volume affecting the learning pro-
cess. Thus, centralizing the procedures to at least MVC/HVC level
might be beneﬁcial even in this respect.
The overall clinically relevant POPF rate in our study was 17.2%,
which is comparable to what has been reported elsewhere. Post-
operative complications occur even in HVCs, and also in this study
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or in Clavien-Dindo 3e5 complications. Nor has a decrease in
overall complication rate or POPF rate after DP been reported in
HVCs vs. LVCs in the literature. However, only few studies report the
rates of complications after DP separately [8]. In our study, DGE
seemed to be more common in LVCs, but the patient records may
not have all the information reliably listed.
Several studies have reported an association between high
hospital volume and lower postoperative mortality in pancreatic
surgery [1,2]. It has been shown that higher mortality in low vol-
ume centres with high-risk surgery is associated with the hospital's
ability to rescue patients from major complications [3,18] The
mortality risk is also attributable to patient characteristics, such as
age and comorbidity [19]. In this study the deaths occurred in the
MVC group and were both sudden and not caused by a treated
complication, but one of themwas associatedwith comorbidity, i.e.,
obesity.
PD has been shown to carry lower mortality and morbidity and
also better oncological outcome in high-volume centres [1,20]. So
far, centralization of DPs in high-volume centres does not seem to
occur, although only few studies have been presented concerning
only DPs in terms of postoperative complications and hospital
volume [8]. One article which claimed that pancreatic resections
can be safely done in MVCs had only 13 DP/11 yrs with a clinically
relevant POPF rate in DP of 32% [21]. Factors favoring centralizing
DP as well as PD include the overall knowledge of pancreatic sur-
gery and its complications and postoperative care. Treatment and
caremay require imaging and interventional radiology around-the-
clock and the decision-making for treatment also needs a multi-
disciplinary approach, which is often lacking in LVC units.
Reasonable volumes are needed to achieve and maintain experi-
enced perioperative management. When analysing all patient re-
cords from each hospital manually we found no differences
between HVCs and LVCs in terms of equipment used in surgery.
Time of drain removal varies within centres according to individual
surgeon. However, we did ﬁnd that multidisciplinary teams were
used in all tertiary but only in some secondary hospitals (HVCs and
MCVs) and in neither of the LVC hospitals. In Finland, where the
population is only 5.4 million and both DP and PC volumes are
generally small, it would be wise to centralize the know-how in
fewer centres in order to achieve the best results.
Risk factors for POPF have been widely studied. A laparoscopic
approach has been shown to reduce the overall complications, but
not POPF [22]. Many closure methods for pancreatic stump have
been developed to reduce the complications, especially POPF. The
pancreas can be closed by suturing or staplers, the stump can be
covered with various patches or meshes or Tachosil [23].
Pancreatico-jejunal anastomosis and preoperative pancreatic stent
have also been used [24,25]. Neither of these has reduced the POPF
rate in RCTs. In a recent RCT a ligament Teres patch was shown to
signiﬁcantly decrease reoperation, readmission and reintervention
rates without affecting the POPF rate [26]. On the pharmaceutical
side, the use of octreotide is controversial. It has no effect on clin-
ically relevant POPF, but it may reduce overall morbidity [27].
Pasireotide has been shown to reduce POPF rate to 7% after DP, in a
recent RCT. High BMI has also been shown to increase themorbidity
rate [28,29]. The effect of hospital volume in DP only has been
poorly reported.
The strength of this study is the nationwide coverage of all DP
operations performed in a single country during the study period.
The study provides valuable information on nationwide DP vol-
umes and complications rates. This is the ﬁrst nationwide study on
DP in Europe.
The weaknesses of this study include the missing and incom-
plete data. Patient data was collected retrospectively from 18different hospitals in Finland and analyzed manually. POPF classi-
ﬁcation was made according the data found by the authors, so the
analysis is consistent throughout the study [11]. Octreotide was not
used routinely in any of the hospitals studied, although some sur-
geons did use it occasionally. It is therefore no included in the
analysis. We could ﬁnd no accurate information on drain removal
time and were therefore unable to include this in the data. . Overall,
the information is missing randomly and should not affect the re-
sults. The hospital volume deﬁnition is somewhat arbitrary, as in
the literature deﬁnitions of volume mostly include both DP and PD.
The number of patients in this study is also rather low since DP was
performed quite rarely, which is also weakness of the study.
In conclusion, this nationwide register study shows similar POPF
and overall complication rates after DPs performed in different
volume hospitals in Finland during the period 2012e1014. How-
ever, there was a signiﬁcant difference in the management of
postoperative complications, as the reoperation rate was signiﬁ-
cantly more common in the LVCs. With experienced postoperative
management, reoperations could possibly be avoided. This may
favour the centralization of pancreatic resections to HVCs e not
only for PD, but also for DP.
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